Robin Besuyen

5PUBLICATIONS
22CO-AUTHORS
Haematological tumoursGene and molecular therapyPredictive and prognostic markersRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 30, 2025
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study.

Rene Westhovens, Kevin L Winthrop, Arthur Kavanaugh

|May 03, 2023
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies.

Walter Reinisch, Wayne Hellstrom, Radboud J E M Dolhain

|Oct 07, 2022
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis.

Bernard Combe, Robin Besuyen, Antonio Gómez-Centeno

|Oct 14, 2021
Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial.

Walter P Maksymowych, Mikkel Østergaard, Robert Landewé

|Feb 02, 2021
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.

Arthur Kavanaugh, Rene R Westhovens, Kevin L Winthrop

Pageof 1

Frequent Collaborators

2 joint publications

Rieke Alten

2 joint publications

Mark C Genovese

2 joint publications

René Westhovens

1 joint publications

Walter P Maksymowych